about
Multimodal management of muscle-invasive bladder cancerA quantitative proteomic analysis uncovers the relevance of CUL3 in bladder cancer aggressiveness.Immunological basis in the pathogenesis and treatment of bladder cancerCancer biomarker discovery: Opportunities and pitfalls in analytical methods.Molecular expression profiling with respect to KEGG hsa05219 pathway.Insights from animal models of bladder cancer: recent advances, challenges, and opportunities.
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Clinical states model for biomarkers in bladder cancer
@en
type
label
Clinical states model for biomarkers in bladder cancer
@en
prefLabel
Clinical states model for biomarkers in bladder cancer
@en
P2093
P2860
P356
P1433
P1476
Clinical states model for biomarkers in bladder cancer
@en
P2093
Andrea B Apolo
Dean F Bajorin
Matthew Milowsky
P2860
P304
P356
10.2217/FON.09.57
P407
P577
2009-09-01T00:00:00Z